Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

6(85.7%)

Phase 1

1(14.3%)

7Total

N/A(6)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06806267Not ApplicableRecruiting

Study of the Effectiveness of VRET Combined With tDCS in the Treatment of PTSD in Ukrainian Veterans and Civilians

Role: collaborator

NCT07046949Not ApplicableCompleted

Anterior Quadratus Lumborum Block as a Component of Multimodal Analgesia for Abdominal Hysterectomies

Role: collaborator

NCT06616168Phase 1Active Not Recruiting

Urogenital Infections in Women of Reproductive Age and the Activity of 4-Thiazolidinone Derivatives Against Pathogens

Role: lead

NCT06508398Completed

Healthcare-Associated Infections in Ukraine and the Activity of 4-Thiazolidinone Derivatives Against Related Pathogens

Role: lead

NCT06352697Not ApplicableCompleted

Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults MASLD Patients (DELI_MASLD Study)

Role: collaborator

NCT05804422Not ApplicableCompleted

Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults NAFLD Patients (DELI_NAFLD Study)

Role: collaborator

NCT05770076Not ApplicableCompleted

Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Type 2 Diabetes Patients (DELI_Diab Study)

Role: collaborator

NCT05765292Not ApplicableCompleted

Probiotic Supplementation and Pancreatic β-Cell Function in Type 2 Diabetes

Role: collaborator

NCT03222375Recruiting

SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism

Role: collaborator

All 9 trials loaded